News | April 10, 2026
Zeto gains FDA nod for new outpatient EEG system promising faster brain health testing
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
The approval comes after a systematic review of published literature
Under the deal, Quiver will receive an undisclosed advance payment and research support
Bocunebart works by blocking pituitary adenylate cyclase-activating polypeptide
_256_384.png)
India presents one of the world’s largest untapped opportunities for neurovascular screening
Under the partnership, the Pfizer INDovation program will empower DPIIT-recognized startups with grants of up to Rs. 60 lakhs each, along with a tailored 18-month incubation program delivered by Social Alpha
Subscribe To Our Newsletter & Stay Updated
